If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Software Group Regulatory News (APTD)

Share Price Information for Aptitude Software Group (APTD)

Share Price is delayed by 15 minutes
Get Live Data
198.00    -15.00 (-7.04%)
Bid:
196.50
Ask:
204.00
Spread: 7.50 (3.817%)
Market Cap: £105.97m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Software Group Share Chart

Board Transition

5 Feb 2025 07:01

RNS Number : 9187V
Aptitude Software Group PLC
05 February 2025
 

5 February 2025

Aptitude Software Group plc

("Aptitude", "the Group")

Board Transition

Aptitude (LSE:APTD), a market-leading provider of finance transformation software solutions, specialising in fully autonomous finance, today provides an update regarding a Board change.

The Aptitude organisation has been realigned to support the new product and business priorities, including the creation of a smaller, globally integrated senior management team with increased travel requirements and expanded spans of control. As a result, by mutual agreement, Mike Johns will step down from his role as CFO and from the Aptitude Board. Mike has agreed to remain in his role and as a Director of the Group to support the business, oversee the Full Year 2024 results and ensure an orderly transition. The search for his successor has commenced, and the Group will share further details in due course.

The Board would like to extend its thanks to Mike for his support of Aptitude over his seven years with the Group. In preparation for this transition, the financial and commercial functions have been strengthened while we appoint Mike's successor. A further update will be provided when Mike steps down from the Aptitude Board.

 

Aptitude Software Group plc

020-3687-3200

 

Alex Curran, Chief Executive Officer

Ivan Martin, Chairman

 

Mike Johns, Chief Financial Officer

 

 

 

Canaccord Genuity Limited

020-7523-8000

Simon Bridges / Andrew Potts

 

 

 

Alma Strategic Communications

 

Caroline Forde / Hilary Buchanan

020-3405-0205

 

 About Aptitude Software

Aptitude Software provides software solutions that deliver fully autonomous finance to enable its clients to drive growth, efficiency and sustainability. Fynapse is Aptitude's intelligent finance data management and accounting platform designed to increase productivity and lower costs for finance teams globally. Fynapse provides a single view of finance and business data, unparalleled performance and automation, faster and better insights, user-friendly functionality and market-leading total cost of ownership

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASSUFALEISEIE
Date   Source Headline
6th Jul 20207:21 amRNSHolding(s) in Company
3rd Jul 20207:00 amRNSTrading Update and Notice of Results
11th Jun 20204:41 pmRNSSecond Price Monitoring Extn
11th Jun 20204:36 pmRNSPrice Monitoring Extension
10th Jun 20204:35 pmRNSPrice Monitoring Extension
2nd Jun 20204:41 pmRNSSecond Price Monitoring Extn
2nd Jun 20204:35 pmRNSPrice Monitoring Extension
1st May 20207:00 amRNSTotal Voting Rights
29th Apr 202012:16 pmRNSDisclosure of Rights attached to Ordinary Shares
28th Apr 202012:45 pmRNSResult of AGM
21st Apr 20207:00 amRNSCOVID-19 Update and AGM Arrangements
8th Apr 20205:02 pmRNSDirector/PDMR Shareholding
8th Apr 20204:59 pmRNSDirector/PDMR Shareholding
27th Mar 202012:38 pmRNSBlock listing Interim Review
18th Mar 20205:00 pmRNSAnnual Report and Notice of AGM
16th Mar 20201:52 pmRNSBlock Listing Application
13th Mar 20205:11 pmRNSDirector/PDMR Shareholding
11th Mar 20207:00 amRNSAudited Preliminary Results
13th Feb 20205:26 pmRNSHolding(s) in Company
3rd Feb 20201:54 pmRNSTotal Voting Rights
22nd Jan 20202:44 pmRNSHolding(s) in Company
20th Jan 20207:00 amRNSTrading Update, Board Changes & Notice of Results
15th Jan 202012:01 pmRNSHolding(s) in Company
3rd Jan 202012:07 pmRNSSecond Price Monitoring Extn
3rd Jan 202012:02 pmRNSPrice Monitoring Extension
3rd Jan 20207:00 amRNSTotal Voting Rights
3rd Dec 20192:52 pmRNSHolding(s) in Company
2nd Dec 201910:28 amRNSTotal Voting Rights
12th Nov 20191:48 pmRNSDirector/PDMR Shareholding
11th Nov 20197:00 amRNSHolding(s) in Company
1st Nov 20197:00 amRNSTotal Voting Rights
29th Oct 20197:00 amRNSAward of Options
23rd Oct 20193:19 pmRNSHolding(s) in Company
4th Oct 20197:00 amRNSChange of Auditor and Partner Programme
30th Sep 20196:03 pmRNSHolding(s) in Company
30th Sep 20197:21 amRNSHolding(s) in Company
27th Sep 20199:35 amRNSHolding(s) in Company
26th Sep 20192:25 pmRNSBlock Listing Interim Review
26th Sep 20198:30 amRNSAcceptance of the B Share Purchase Offer
25th Sep 20198:00 amRNSPurchase Offer for B Shares
24th Sep 20197:00 amRNSIssue of B Shares and Share Consolidation
23rd Sep 20191:50 pmRNSReturn of Value and Result of GM
11th Sep 20196:03 pmRNSHolding(s) in Company
9th Sep 20192:27 pmRNSHolding(s) in Company
9th Sep 20192:13 pmRNSHolding(s) in Company
3rd Sep 20197:00 amRNSPublication of Circular and Notice of GM
2nd Sep 20194:16 pmRNSCorrection: Issue of Consideration Shares
2nd Sep 20191:37 pmRNSConfirmation of Directorate Change
2nd Sep 20197:00 amRNSIssue of Consideration Shares
29th Aug 20191:23 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.